Coulie Bernard
SEC insider (Form 3/4/5 filer). CIK 0001808895. President and CEO at PLIANT THERAPEUTICS, INC. (PLRX) and 1 other issuer. 19 reported Form 4/5 transactions since Sep 2024; latest on Apr 17, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Coulie Bernard has filed insider reports for
- PLIANT THERAPEUTICS, INC. (PLRX): Director, Officer, President and CEO
- Septerna, Inc. (SEPN): Director
Coulie Bernard
CIK: 0001808895
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (19 total)
- Apr 17, 2026PLRX
PLIANT THERAPEUTICS, INC.
DispositionDirectStock Option (Right to Buy)
256.3K shares- - Apr 17, 2026PLRX
PLIANT THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
325K shares- - Apr 17, 2026PLRX
PLIANT THERAPEUTICS, INC.
DispositionDirectStock Option (Right to Buy)
325K shares- - Apr 17, 2026PLRX
PLIANT THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
256.3K shares- - Apr 17, 2026PLRX
PLIANT THERAPEUTICS, INC.
DispositionDirectStock Option (Right to Buy)
146.8K shares- - Apr 17, 2026PLRX
PLIANT THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
146.8K shares- - Apr 17, 2026PLRX
PLIANT THERAPEUTICS, INC.
DispositionDirectStock Option (Right to Buy)
327.3K shares- - Apr 17, 2026PLRX
PLIANT THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
327.3K shares- - Apr 17, 2026PLRX
PLIANT THERAPEUTICS, INC.
DispositionDirectStock Option (Right to Buy)
250K shares- - Apr 17, 2026PLRX
PLIANT THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
250K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 17, 2026 |  PLRX PLIANT THERAPEUTICS, INC. | Disposition Stock Option (Right to Buy) | 256,300 | - | - | Direct |
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 325,000 | - | - | Direct |
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | Disposition Stock Option (Right to Buy) | 325,000 | - | - | Direct |
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 256,300 | - | - | Direct |
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | Disposition Stock Option (Right to Buy) | 146,841 | - | - | Direct |
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 146,841 | - | - | Direct |
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | Disposition Stock Option (Right to Buy) | 327,262 | - | - | Direct |
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 327,262 | - | - | Direct |
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | Disposition Stock Option (Right to Buy) | 250,000 | - | - | Direct |
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 250,000 | - | - | Direct |
1-10 of 19 transactions